Contraception and health

The Lancet

Volumn 380, Issue 9837, 2012, Pages 149-156

  Cleland, John ^a   Conde Agudelo, Agustin ^b,c   Peterson, Herbert ^d,e   Ross, John ^f   Tsui, Amy ^g  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c HUTZEL HOSPITAL   (United States)

^d IL   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f Palladium Group   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; CONTRACEPTIVE AGENT;

ABORTION; ANEMIA; BREAST CANCER; CANCER RISK; CHILDHOOD MORTALITY; CONTRACEPTION; ENDOMETRIUM CANCER; FERTILITY; HIGH RISK PREGNANCY; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; INTRAUTERINE CONTRACEPTIVE DEVICE; MATERNAL CARE; MATERNAL MORTALITY; MENSTRUATION; ORAL CONTRACEPTION; OSTEOLYSIS; OVARY CANCER; PAPILLOMAVIRUS INFECTION; PERINATAL CARE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SURVIVAL; UNSPECIFIED SIDE EFFECT; UNWANTED PREGNANCY; UTERINE CERVIX CANCER; UTERINE TUBE STERILIZATION; VASECTOMY; ADOLESCENT; ADULT; ARTICLE; BIRTH RATE; CHILD; CHILD WELFARE; FAMILY PLANNING; FEMALE; INFANT; MIDDLE AGED; PARITY; PREGNANCY; PREGNANCY OUTCOME; RISK FACTOR; STATISTICS; UTILIZATION REVIEW; WOMEN'S HEALTH;

ADOLESCENT; ADULT; BIRTH INTERVALS; BIRTH RATE; CHILD; CHILD MORTALITY; CHILD WELFARE; CONTRACEPTION; CONTRACEPTIVE AGENTS; FAMILY PLANNING SERVICES; FEMALE; HUMANS; INFANT; INFANT MORTALITY; INTRAUTERINE DEVICES; MATERNAL MORTALITY; MIDDLE AGED; PARITY; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREGNANCY, UNWANTED; RISK FACTORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84863725247     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60609-6     Document Type: Review

References (75)

1. Koenig MA, Fauveau V, Chowdhury AI, Chakraborty J, Khan MA. Maternal mortality in Matlab Bangladesh 1976-85. Stud Fam Plann 1988; 19: 69-80.
2. Bhatia J. Levels and causes of maternal mortality in southern India. Stud Fam Plann 1993; 24: 310-18.
3. Wee DW, Mullany LC, Katz J, Khatry SK, LeClerq SC, Tielsch JM. Pregnancy-related mortality in southern Nepal between 2001 and 2006: independent estimates from a prospective, population-based cohort and a direct sisterhood survey. Am J Epidemiol 2010; 172: 855-60.
4. Atrash HK, Koonin LM, Lawson HWA, Franks AL, Smith JC. Maternal mortality in the United States, 1979-1986. Obstet Gynecol 1990; 76: 1055-60.
5. Cecatti J, Correa-Silva EPB, Milanez H, Moraise SS, Souza JP. The associations between inter-pregnancy interval and maternal and neonatal outcomes in Brazil. Matern Child Health J 2008; 12: 275-81.
6. Jain AK. Measuring the effect of fertility decline on the maternal mortality ratio. Stud Fam Plann 2011; 18: 247-60.
7. Fortney J. The importance of family planning in reducing maternal mortality. Stud Fam Plann 1987; 18: 109-14.
8. Trussell J, Pebley A. The potential impact of changes in fertility on infant, child and maternal mortality. Stud Fam Plann 1984; 15: 267-80.
9. Winikoff B, Sullivan M. Assessing the role of family planning in reducing maternal mortality. Stud Fam Plann 1987; 18: 128-43.
10. National Institute of Population Research and Training, ORC Macro. Bangladesh maternal health services and maternal mortality survey 2001. Dhaka, Bangladesh, and Calverton, MD: NIPORT, ORC Macro, 2003.
11. Magadi M, Diamond I, Madise N. Analysis of factors associated with maternal mortality in Kenyan hospitals. J Biosoc Sci 2001; 33: 375-89.
12. Yerushalmy J, Palmer C, Kramer M. Studies in childbirth mortality: age and birth as factors in puerperal fatality. Public Health Rep 1940; 55: 1195-20.
13. Ujah IAO, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE. Factors contributing to maternal mortality in North-central Nigeria: a seventeen-year review. Afr J Reprod Health 2003; 9: 27-39.
14. Tuncer RA, Erkaya S, Sipahi T, Kutlar I. Maternal mortality in a maternity hospital in Turkey. Acta Obstet Gynecol Scand 1995; 74: 604-06.
15. Mhango C, Rochat R, Arkutu A. Reproductive mortality in Lusaka, Zambia, 1982-83. Stud Fam Plann 1986; 17: 243-51.
16. Fikree F, Midhet F, Sadruddin S, Berendes H. Maternal mortality in different Pakistani sites: ratios, clinical causes and determinants. Acta Obstet Gynecol Scand 1997; 16: 637-45.
17. Garenne M, Mbaye K, Bah MD, Correa P. Risk factors for maternal mortality: a case-control study in Dakar hospitals (Senegal). Afr J Reprod Health 1997; 1: 14-24.
18. Bouvier-Colle MH, Ouedraogo C, Dumont A, Vangeenderhuysen C, Salanave B, Decam C. Maternal mortality in West Africa: rates, causes and substandard care from a prospective survey. Acta Obstet Gynecol Scand 2001; 80: 113-19.
19. Conde-Agudelo A, Belizán JM. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. BMJ 2000; 321: 1255-59.
20. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. effects of birth spacing on maternal health: a systematic review. Am J Obstet Gynecol 2007; 196: 297-308.
21. Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends and outcomes. Stud Fam Plann 2010; 41: 241-50.
22. Sedgh G, Henshaw S, Singh S, Åhman E, Shah IH. Induced abortion: estimated rates and trends worldwide. Lancet 2007; 370: 1338-45.
23. Shah I, Ahman E. New estimates and trends regarding unsafe abortion mortality. Int J Gynaecol Obstet 2011; 115: 1338-45.
24. WHO. Unsafe abortion. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. Geneva: World Health Organization, 2011.
25. Ross J, Blanc AK. Why aren't there more maternal deaths? A decomposition analysis. Matern Child Health J 2012; 16: 456-63.
26. Darroch J, Singh S, for the Guttmacher Institute. Estimating unintended pregnancies averted from couple-years of protection (CYP). New York: Guttmacher Institute, 2011.
27. WHO. Trends in maternal mortality: 1990 to 2008. Geneva: World Health Organization, 2010.
28. Ahmed S, Li Q, Liu L, Tsui AO. Maternal deaths averted by contraceptive use: an analysis of 172 countries. Lancet 2012; published online July 10. http://dx.doi.org/10.1016/S0140-6736(12)60478-4.
29. Collumbien M, Gerressu M, Cleland J. Non-use and use of ineffective methods of contraception. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative quantification of health risks, global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization, 2004: 1255-320.
30. Singh S, Darroch JE, Ashford LS, Vlassoff M. Adding it up: the costs and benefits of investing in family planning and maternal and newborn health. New York: Guttmacher Institute, 2009.
31. Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA 2006; 295: 1809-23.
32. DeFranco EA, Stamilio DM, Boslaugh SE, Gross GA, Muglia LJ. A short interpregnancy interval is a risk factor for preterm birth and its recurrence. Am J Obstet Gynecol 2007; 197: 264.e1-e6.
33. Rodrigues T, Barros H. Short interpregnancy interval and risk of spontaneous preterm delivery. Eur J Obstet Gynecol Reprod Biol 2008; 136: 184-88.
34. Auger N, Daniel M, Platt RW, Luo ZC, Wu Y, Choinière R. The joint influence of marital status, interpregnancy interval, and neighborhood on small for gestational age birth: a retrospective cohort study. BMC Pregnancy Childbirth 2008; 8: 7.
35. Nabukera SK, Wingate MS, Kirby RS, et al. Interpregnancy interval and subsequent perinatal outcomes among women delaying initiation of childbearing. J Obstet Gynaecol Res 2008; 34: 941-47.
36. Grisaru-Granovsky S, Gordon ES, Haklai Z, Samueloff A, Schimmel MM. effect of interpregnancy interval on adverse perinatal outcomes\a national study. Contraception 2009; 80: 512-18.
37. Cecatti JG, Correa-Silva EP, Milanez H, Morais SS, Souza JP. The associations between inter-pregnancy interval and maternal and neonatal outcomes in Brazil. Matern Child Health J 2008; 12: 275-81.
38. Williams EK, Hossain MB, Sharma RK, Kumar V, Pandey CM, Baqui AH. Birth interval and risk of stillbirth or neonatal death: findings from rural north India. J Trop Pediatr 2008; 54: 321-27.
39. Adam I, Ismail MH, Nasr AM, Prins MH, Smits LJ. Low birth weight, preterm birth and short interpregnancy interval in Sudan. J Matern Fetal Neonatal Med 2009; 22: 1068-71.
40. Smits LJ, Essed GG. Short interpregnancy intervals and unfavourable pregnancy outcome: role of folate depletion. Lancet 2001; 358: 2074-77.
41. Zhu BP, Rolfs RT, Nangle BE, Horan JM. effect of the interval between pregnancies on perinatal outcomes. N Engl J Med 1999; 340: 589-94.
42. Rutstein SO. Further evidence of the effects of preceding intervals on neonatal, infant and under-five-years mortality and nutritional status in developing countries: evidence from the Demographic and Health Surveys. Demographic and Health Surveys working paper 2008 no. 41. Calverton, MD: Macro International, 2008.
43. Rutstein SO, Johnson K, Conde-Agudelo A, Rosas-Bermudez A. effect of birth spacing on infant and child mortality: a systematic review and meta-analysis. WHO technical consultation and scientific review of birth spacing; Geneva; June 13-15, 2005.
44. Hobcraft J, McDonald JW, Rutstein SO. Child spacing effects on infant and early child mortality. Popul Index 1983; 49: 585-618.
45. Hobcraft J, McDonald JW, Rutstein SO. Demographic determinants of infant and child mortality. Popul Stud 1985; 39: 363-85.
46. UN Department for Economic and Social Information Analysis, Population Division. The health rationale for family planning: timing of births and child survival. New York: United Nations, 1994.
47. Rutstein SO. effects of preceding birth intervals on neonatal, infant and under-five years mortality and nutritional status: evidence from demographic and health surveys. Int J Gynaecol Obstet 2005; 89 (suppl 1): S7-24.
48. Mahy M. Childhood mortality in the developing world: a review of evidence from the Demographic and Health Surveys. Demographic and Health Surveys comparative reports no. 4. Caverton, MD: ORC Macro, 2003.
49. Dewey K, Cohen R. Does birth spacing affect maternal and child nutritional status? A systematic review literature review. Matern Child Nutrition 2007; 3: 151-73.
50. Canning D, Ozaltin E, Finlay JE. Association of maternal health with infant mortality, child anthropometric failure, diarrhea and anaemia in low and middle income countries. Boston: Harvard School of Public Health, 2011.
51. Hobcraft J. Does family planning save children's lives? Technical background paper for the International Conference on Better Health for Women and Children through Family Planning; Kenya, Nairobi; October 5-9, 1987.
52. Kost K, Forrest JD, Harlap S. Comparing the health risks and benefits of contraceptive choices. Fam Plann Perspect 1991; 23: 54-61.
53. Peterson HB. Sterilization. Obstet Gynecol 2008; 111: 189-203.
54. Farley TMM, Rowe PJ, Meirik O, Rosenberg MJ, Chen J-H. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339: 785-88.
55. Beining RM, Dennis LK, Smith EM, Dokras A. Meta-analysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol 2008; 18: 492-99.
56. Castellsagué X, Diaz M, Vaccarella S, et al. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol 2011; 12: 1023-31.
57. Franks AL, Beral V, Cates W Jr, Hogue CJR. Contraception and ectopic pregnancy risk. Am J Obstet Gynecol 1990; 163: 1120-23.
58. Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception 2010; 82: 221-29.
59. Petitti DB. Combination estrogen-progestin oral contraceptives. N Engl J Med 2003; 349: 1443-50.
60. Cibula D, Gompel A, Mueck AO, et al. Hormonal contraception and risk of cancer. Hum Reprod Update 2010; 16: 631-50.
61. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet 2008; 371: 303-14.
62. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713-27.
63. Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002; 346: 2025-32.
64. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370: 1609-21.
65. WHO. WHO statement on hormonal contraception and bone health. Wkly Epidemiol Rec 2005; 35: 302-04.
66. Curtis KM, Nanda K, Kapp N. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS 2009; 23 (suppl 1): S55-67.
67. Stringer EM, Levy J, Sinkala M, et al. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS 2009; 23: 1377-82.
68. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012; 12: 19-26.
69. WHO. Hormonal contraception and HIV: technical statement. http://www.who.int/reproductivehealth/topics/family-planning/ Hormonal-contraception-and-HIV.pdf (accessed Feb 24, 2012).
70. Glasier AF, Smith KB, van der Spuy ZM, et al. Amenorrhea associated with contraception-an international study on acceptability. Contraception 2003; 67: 1-8.
71. Ali MM, Cleland J. Contraceptive switching after method-related discontinuation. Stud Fam Plann 2010; 41: 129-33.
72. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010; 375: 1609-23.
73. Goldie SJ, Sweet S, Carvalho N, Natchu UCM, Hu D. Alternative strategies to reduce maternal mortality in India: a cost-effectiveness analysis. PLoS Med 2010; 7: e1000264.
74. Barker DJ. The origins of the development origins theory. J Intern Med 2007; 261: 412-17.
75. WHO. Report of a WHO technical consultation on birth spacing: Geneva, Switzerland 13-15 June, 2005. WHO/RHR/07.1. Geneva: World Health Organization, 2007.